These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 10166472)

  • 21. Department of Justice and Federal Trade Commission issue further guidance relating to physician network joint ventures.
    Becker S
    Benders Health Care Law Mon; 1996 Oct; ():3-4. PubMed ID: 10162603
    [No Abstract]   [Full Text] [Related]  

  • 22. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

  • 23. Ten grains of salt: why not rely solely on the new federal guidelines in evaluating antitrust risks.
    Enders R
    Health Syst Rev; 1996; 29(6):13. PubMed ID: 10167138
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitrust and managed care ... the safety zones.
    Hanna MJ
    Tex Dent J; 1995 Nov; 112(11):68-70. PubMed ID: 9518830
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitrust's expanding universe.
    Back K
    Health Syst Rev; 1996; 29(6):11-2, 14. PubMed ID: 10167137
    [No Abstract]   [Full Text] [Related]  

  • 26. Perspectives. PSNs (provider sponsored networks): nifty concept, thorny complications.
    Cunningham R
    Faulkner Grays Med Health; 1995 Oct; 49(39):suppl 1-4. PubMed ID: 10151107
    [No Abstract]   [Full Text] [Related]  

  • 27. Antitrust evaluation of physician networks.
    Rosen BF; Dietz RL
    Md Med J; 1996 Aug; 45(8):611-3. PubMed ID: 8772273
    [No Abstract]   [Full Text] [Related]  

  • 28. Hope for antitrust relief.
    Besaw L
    Tex Med; 1996 Jun; 92(6):26-9. PubMed ID: 8685841
    [No Abstract]   [Full Text] [Related]  

  • 29. Managed care and antitrust--a guide for provider-sponsored PPOs.
    Hershey D
    Trustee; 1993 Sep; 46(9):12-4. PubMed ID: 10128227
    [No Abstract]   [Full Text] [Related]  

  • 30. Establishing physician networks within evolving antitrust guidelines.
    Retchin TN; Retchin SM
    Clin Perform Qual Health Care; 1997; 5(3):140-5. PubMed ID: 10169186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMA to battle antitrust laws that hinder physician groups.
    Pallarito K
    Mod Healthc; 1993 Sep; 23(38):24. PubMed ID: 10128212
    [No Abstract]   [Full Text] [Related]  

  • 32. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
    Hirshfeld E
    Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
    Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
    [No Abstract]   [Full Text] [Related]  

  • 34. Hospital-sponsored networks. The rush to consolidate and the future of medical practice.
    van Amerongen D
    Physician Exec; 1997 Jan; 23(1):4-8. PubMed ID: 10164290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Converting new antitrust guidance into action.
    Johnson BA
    Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated delivery systems: reforming the conflicts among federal referral, tax exemption, and antitrust laws.
    Woodhall AL
    Health Matrix Clevel; 1995; 5(1):181-248. PubMed ID: 10141744
    [No Abstract]   [Full Text] [Related]  

  • 38. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
    Ewing KP; Koslov TI
    Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
    [No Abstract]   [Full Text] [Related]  

  • 40. This monopoly is state-approved. Maine Heart Surgical Associates.
    Pretzer M
    Med Econ; 1997 May; 74(11):131-4. PubMed ID: 10167616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.